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ABSTRACT   49 
Background: Exposure to trihalomethanes (THMs) in drinking water has consistently 50 
been associated with an increased risk of bladder cancer, but evidence on other cancers 51 
including the breast is very limited.  52 
Objectives: We assessed long-term exposure to THMs to evaluate the association with 53 
female breast cancer (BC) risk. 54 
Methods: A multi case-control study was conducted in Spain from 2008 to 2013. We 55 
included 1,003 incident BC cases (women 20-85 years old) recruited from 14 hospitals 56 
and 1,458 population controls. Subjects were interviewed to ascertain residential 57 
histories and major recognized risk factors for BC. Mean residential levels of 58 
chloroform, brominated THMs (Br-THMs) and the sum of both as total THM (TTHMs) 59 
during the adult-lifetime were calculated. 60 
Results: Mean adult-lifetime residential levels ranged from 0.8 to 145.7 µg/L for TTHM 61 
(median=30.8), from 0.2 to 62.4 µg/L for chloroform (median=19.7) and from 0.3 to 62 
126.0 µg/L for Br-THMs (median=9.7). Adult-lifetime residential chloroform was 63 
associated with BC (adjusted OR=1.47; 95%CI=1.05, 2.06 for the highest (>24 µg/L) 64 
vs. lowest (<8 µg/L) quartile; p-trend=0.024). No association was detected for 65 
residential Br-THMs (OR=0.91; 95%CI=0.68, 1.23 for >31 µg/L vs. <6 µg/L) or 66 
TTHMs (OR=1.14; 95%CI=0.83, 1.57 for >48 µg/L vs. <22 µg/L). 67 
Conclusions: At common levels in Europe, long-term residential total THMs were not 68 
related to female breast cancer. A moderate association with chloroform was suggested 69 
at the highest exposure category. This large epidemiological study with extensive 70 
exposure assessment overcomes several limitations of previous studies but further 71 
studies are needed to confirm these results.  72 
5 
 
1. INTRODUCTION 73 
Breast cancer (BC) is the first cancer in incidence and mortality among women world-74 
wide (Globocan 2012), with an increasing incidence during the last decades, also in 75 
Spain (Pollán et al. 2009). BC is more common in western countries and among 76 
favoured socioeconomic status (Brody and Rudel 2003). Main recognized risk factors 77 
affect endogenous estrogenic levels (Hankinson et al. 2004) and include sex, age, body 78 
mass index, age at menarche, at first delivery and at menopause, life-style factors such 79 
as alcohol consumption and low physical activity, and drugs with estrogenic action 80 
before or after menopause (Hankinson et al. 2004). Established risk factors explain 81 
approximately 50% of the variability in BC incidence, and other environmental factors 82 
may partly explain the remaining variation (Brody et al. 2007). Toxicological studies, 83 
and to a lesser extend epidemiological studies, have related some environmental 84 
exposures to BC (Macon et al. 2013), mainly through endocrine disruption (Brody and 85 
Rudel 2003). Drinking water disinfection by-products (DBP) are among the chemicals 86 
suggested by toxicologic research as potentially related to BC that have not been 87 
investigated enough in epidemiologic studies (Brody et al. 2007).  88 
DBPs are a mixture of hundreds of chemicals formed in water during the disinfection 89 
process. This is a ubiquitous exposure through ingestion of tap water, inhalation and 90 
dermal exposure during showering, bathing or washing dishes (Villanueva et al. 2015). 91 
The most prevalent DBP in drinking water are trihalomethanes (THM), which are the 92 
only DBP group regulated in the EU with a maximum contaminant level of 100 μg/L. 93 
Several DBPs have been shown to be genotoxic in in vitro assays and carcinogenic in 94 
animal experiments (Richardson et al. 2007) and the WHO International Agency for 95 
Research on Cancer (IARC) classifies chloroform and other widespread DBP as 96 
possible humans carcinogens (Villanueva et al. 2015). Several epidemiological studies 97 
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have related exposure to DBPs and cancer risk, being the most consistent evidence for 98 
bladder cancer and in a lower extent for colon and rectal cancer (Villanueva et al. 2015). 99 
Only sporadic epidemiological studies have assessed the impact of DBPs on other 100 
cancer sites including the breast (Villanueva et al. 2015).  101 
Among the few epidemiological studies on DBP exposure and BC, some detected a 102 
positive association (Doyle et al. 1997; Gottlieb et al. 1982; Koivusalo et al. 1997; 103 
Wilkins and Comstock 1981), while others did not (Kanarek et al. 1982; Marcus et al. 104 
1998; Vincetti et al. 2004; Young et al. 1981; Zierler et al. 1986). These are studies 105 
conducted 20 years ago (Doyle et al. 1997; Koivusalo et al.  1997; Marcus et al. 1998) 106 
or 30 (Gottlieb et al. 1982; Kanarek et al. 1982; Wilkins and Comstock  1981; Young et 107 
al. 1981; Zierler et al. 1986) with only one exception (Vincetti et al. 2004) and had 108 
important methodological limitations, including an ecological design (Marcus et al. 109 
1998; Vincetti et al. 2004; Wilkins and Comstock  1981), a poor control for 110 
confounding and a very limited exposure assessment based on surrogates of DBP 111 
exposure (Doyle et al. 1997; Gottlieb et al. 1982; Kanarek et al. 1982; Koivusalo et al. 112 
1997; Young et al. 1981). Furthermore, evidence that 3-Chloro-4-(dichloromethyl)-5-113 
hydroxy-2(5H)-furanone (MX), a major mutagenic constituent of DBP, causes 114 
mammary tumours in rats (Komulainen et al. 1997) also suggests that the association 115 
between DBP exposure and BC should be further investigated in epidemiological 116 
studies overcoming the limitations of previous studies (Brody et al. 2007). 117 
We aim to provide new epidemiological evidence on the association between lifetime 118 
exposure to DBPs and female BC risk in a large case-control study, including areas with 119 
contrasting THM concentrations in Spain and evaluating different routes of exposure 120 
and THM species.  121 
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2. METHODS  122 
2.1. Study design and population  123 
A multi case-control study was conducted from 2008 to 2013 in twelve provinces of 124 
Spain (MCC-Spain project) (Castano-Vinyals et al. 2015). Women 20-85 years old with 125 
histologically confirmed incident BC (International Classification of Diseases 10th 126 
Revision [ICD-10]: C50, D05.1, D05.7) without personal cancer history were recruited 127 
from oncologic and surgical services in fourteen hospitals from eight provinces. 128 
Controls were selected randomly from the rosters of General Practitioners at the 129 
Primary Health Centers participating in the study covering nearly all the population 130 
living in the corresponding area, allowing to identify population-based controls from the 131 
same study base as cases. Controls were frequency matched to cases by age in 5-year 132 
age groups and study area. They were contacted on behalf of their General Practitioner 133 
and invited to participate in the study. Subjects with serious barriers to communication 134 
were excluded. Average response rate was 71% for cases and 53% for controls. The 135 
study protocol was approved by the ethical review board from participating centers and 136 
all participants signed an informed consent before recruitment. 137 
2.2. Individual information 138 
A structured computerized questionnaire was administered by trained personnel in face-139 
to-face interviews to collect data on residential history, water source in each residence 140 
(bottled, tap, other) and frequency and duration of bathing, showering and hand dish-141 
washing. Several potential risk factors were also collected including age (continuous), 142 
educational level (less than primary school, primary school, secondary school and 143 
university), occupational status (working, not working, housewife, retired), race (white, 144 
others), weight and height to compute body mass index (BMI; <25, 25-29.9, =>30), 145 
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family history of BC (yes/no), menopausal status (pre/post), menopause treatment (ever, 146 
never), oral contraceptive use (never, ever), nulliparity (yes, no), age at menarche 147 
(continuous,  and categorized to: <=12, 13-14, >14 years), age at first birth (continuous, 148 
and categorized to: <25, 25-28, >28 years), breastfeeding (continuous, and categorized 149 
to: 0, >0-6, >6-12, >12 months), smoking (never, former or current), average leisure 150 
physical activity in the last 10 years (continuous frequency and duration converted to 151 
metabolic equivalents of task (METS)/hour/week). Diet habits and alcohol consumption 152 
was reported through a self-administered semi-quantitative food-frequency 153 
questionnaire and current energy intake (<1500, 1500-2000, >2000 kcal/day) and intake 154 
of alcohol in the past (0, 0-5.5, >5.5 grams/day) were calculated. Long-term waterborne 155 
ingested nitrate was also estimated (Espejo-Herrera et al. 2016) and levels were 156 
categorized in quartiles. Missing data in categorical variables were classified as a 157 
separate category.  158 
2.3. Historical trihalomethane levels in the study area 159 
We used trihalomethanes as a surrogate of DBPs. We collected historical information 160 
on water source, treatment and routine THM measurements in the study areas through 161 
water utilities, local authorities and health authorities. Historical THM levels back to 162 
1940 were modeled at water zone level, the minimum geographic unit with 163 
homogeneous water source, treatment and THM levels (corresponding to municipality 164 
in most cases). Annual average THM levels were calculated using available 165 
measurements. For years when THM measurements were absent, available THM levels 166 
were averaged and imputed if water source and treatment were unchanged. Proportion 167 
of surface water and type of treatment were used as a weight to this average in the event 168 
of changes in water source and treatment. Before chlorination started, THM levels were 169 
assumed to be zero. Total THMs (TTHMs) was calculated summing up the 170 
9 
 
concentrations of the four THMs (chloroforom, bromodichloromethane, 171 
dibromochloromethane, and bromoform). Brominated THMs (Br-THMs) were 172 
calculated as the TTHMs excluding chloroform. Correlation between residential levels 173 
of chloroform, Br-THMs and TTHMs was explored with Spearman correlation.   174 
2.4. Individual exposure in the study population  175 
THM levels and subjects’ personal data were linked by year and water zone of residence 176 
to obtain an annual THM level in the residences where subjects lived from age 18 to 2 177 
years before the interview. Average levels in all residences with THM estimates was 178 
then calculated and referred as adult-lifetime residential levels. Average residential 179 
THM levels in the last 10 years were also calculated as an alternative exposure window 180 
with more accurate exposure estimates. The type of water consumed in the residence 181 
and liters/day ingested were used to calculate ingested THM levels, by multiplying 182 
residential levels if tap water was consumed, and a zero THM level if water ingested 183 
was bottled (Font-Ribera et al. 2010). When water consumed was from private wells, 184 
levels assigned were 0.3, 0.3, 0.8, and 1.8 µg/L respectively for chloroforom, 185 
bromodichloromethane, dibromochloromethane and bromoform, according to 186 
unpublished records from wells in the study areas. Average ingested TTHMs and Br-187 
THMs level in the residences was calculated for the years with available data and 188 
expressed as µg/day. Exposure through showering, bathing and hand dish-washing was 189 
estimated by multiplying minutes/week of each activity by the residential TTHMs or 190 
Br-THMs level and expressed as µg/L x min/week. When gloves were used “most of 191 
the time” for hand dish-washing (16.9% of subjects), half of the THM exposure was 192 
assigned.  193 
2.5. Statistical analysis  194 
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The initial sample of BC cases and controls in the study areas with modeled THM was 195 
3,322 (1,582 cases and 1,740 controls). Only subjects with known THM concentrations 196 
in the residential tap water for at least 70% of the years between age 18 to 2 years 197 
before the interview (87% of interviewed subjects) were included. In order to have a 198 
similar geographical distribution of cases and controls, only municipalities with at least 199 
one case and one control were included and 9 controls and 278 cases living in 117 small 200 
municipalities not accomplishing this criteria were excluded. One subject with 201 
unreliable interview was further excluded, as well as fourteen controls that had missing 202 
data in physical activity, a variable included in all final models. Analyzed sample 203 
included 2,461 subjects, 1,003 cases and 1,458 controls. 204 
The main models estimated the association between BC and average adult-lifetime 205 
residential TTHMs, chloroform and Br-THMs levels. Generalized additive models 206 
(GAM) were used to evaluate the exposure-response relationships on continuous 207 
variables. Exposure variables were categorized into quartiles defined according to the 208 
exposure distribution among controls. We estimated odds ratios (OR) and 95% 209 
confidence intervals (CI) of BC using mixed models with recruitment area as random 210 
effect. Additional models explored the association with residential THM levels in the 211 
last 10 years, mutual adjustment between residential chloroform and residential Br-212 
THMs as well as interaction by menopausal status. We estimated OR of BC for specific 213 
exposure routes: drinking water source in the longest residence, time showering, time 214 
washing dishes by hand, THM exposure through ingestion, through showering and 215 
through hand dish-washing.  216 
All models were adjusted for age, area and education. Further adjustment included 217 
known risk factors for BC that were significant in the models (p-value <0.05) and those 218 
that changed the risk estimates (beta) >10%. Main models were adjusted for area, age, 219 
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educational level, occupational status, family history of BC, BMI, energy intake, 220 
physical activity, oral contraceptive use and menopause treatment use. Multicollineality 221 
was explored using the variance inflation factor (VIF), having all variable categories a 222 
VIF<4 (except the highest quartile of TTHM and three study areas) with a mean of 2.66 223 
in the model for life-time average residential TTHM. Statistical analyses were 224 
performed using STATA version 12.0 (Stata Corp, College Station, TX). 225 
 226 
3. RESULTS 227 
1003 cases and 1458 controls were included from ten study areas in Spain (Table 1). 228 
After adjusting by area, age and educational level, cases showed higher frequencies of 229 
family history of BC, overweight and obesity, occupational status, never use of 230 
menopause treatment, never use of oral contraceptives, being physically inactive and 231 
high energy intake. The OR of BC for these and other classical BC risk factors can be 232 
found in Table S1. Compared to women excluded for the final analysis, the included 233 
population had a higher proportion of controls, postmenopausal women, and a lower 234 
proportion of women of young age, working status and highest energy intake (Table 235 
S1). The geographical distribution of the residencies of cases and controls is shown in 236 
Figure S1.    237 
Average adult-lifetime residential levels of TTHMs ranged from 0.8 to 145.7 µg/L 238 
among study participants (Figure 1), with a median level of 30.8 µg/L (interquartile 239 
range (IQR)=22.3, 51.6) for TTHMs, 19.7 µg/L (IQR=7.8, 24.5) for chloroform and 9.7 240 
µg/L (IQR=5.3, 28.5) for Br-THMs. Exposure to residential chloroform ranged between 241 
0.8 and 62.4 µg/L, while exposure to Br-THMs ranged from 1.9 to 126.0 µg/L. The 242 
variability of residential THMs within area was small for several areas, what precluded 243 
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the estimation of overall effects through meta-analysis. The proportion of chloroform 244 
from TTHMs differed among areas, from 11% in Valencia to 88% in Madrid, and the 245 
Spearman correlation between chloroform and Br-THMs also differed between areas, 246 
being -0.26 overall (Figure S2).  247 
Generalized additive models showed a positive linear relationship between BC and 248 
average adult-lifetime residential levels of TTHMs, chloroform and Br-THM (Figure 2). 249 
When exposure was categorized into quartiles, no significant association was seen 250 
between BC and TTHMs or Br-THMs (Table 2). The OR for the highest vs. lowest 251 
quartile of TTHM (>48.3 µg/L vs. <= 21.7µg/L) was 1.14 (95%CI=0.83, 1.57). 252 
Residential levels of chloroform were related to BC (OR=1.47 (95%CI=1.05, 2.06) for 253 
the highest vs. lowest quartile (>24.3 µg/L vs. <=7.6 µg/L)) and a p-trend value of 254 
0.028. A positive association was also observed with residential chloroform as a 255 
continuous variable with an OR of 1.12 (0.98, 1.27) for a 10 µg/L increase. After further 256 
adjustment for residential levels of Br-THMs, the association between BC and 257 
residential chloroform remained very similar and there was no collinearity in the model 258 
(mean VIF for the two variables=1.89). No significant interaction was observed 259 
between residential THM levels and menopausal status on BC risk, although slightly 260 
higher associations among pre-menopausal women were found at the highest exposure 261 
category (Table S3). Likewise, no interaction was observed between residential TTHMs 262 
and chloroform levels and educational level on BC risk, while a significant interaction 263 
was detected for Br-THMs level. The OR for BC among those in the highest vs. lowest 264 
quartile of residential Br-THMs level was lower among those with primary or less 265 
education (OR=0.69; 95%CI=0.48, 1.01) than among those with secondary or more 266 
education (OR=1.36; 95%CI=0.83, 2.24) (Table S4). Further adjustment of the 267 
residential THM models by other socioeconomic status variables (partner educational 268 
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level, social class by the largest occupation and parental socioeconomic status) gave 269 
similar results (Table S5).  270 
In the Barcelona metropolitan area, with the highest levels of Br-THMs and TTHMs, 271 
exposure to residential Br-THMs and TTHMs were also related to BC (OR=1.76 272 
(95%CI=0.80, 3.90) for the highest (>91.8 µg/L) vs. lowest (<48.8 µg/L) quartiles of 273 
Br-THMs and OR=1.72 (95%CI=0.79, 3.78) for the highest (>110.5 µg/L) vs. lowest 274 
(<71.1 µg/L) quartiles of TTHMs) (Table S6). Madrid, the largest city in Spain and the 275 
study area contributing with more subjects, had very low variability in THM levels and 276 
no association between those and BC was detected (Table S6).   277 
Average residential THM levels during the last 10 years were highly correlated to 278 
average adult-life levels (spearman correlations of 0.80, 0.92 and 0.85 for TTHMs, Br-279 
THMs and chloroform, respectively (all p-values <0.001). OR of BC for residential 280 
THM levels in the last 10 years were therefore very similar to those for adult-life time 281 
residential THM levels (Table S7).  282 
Approximately 75% of the study population usually drank municipal water in their 283 
longest residence (28.4 years duration in average), while 21% drank bottled water, and 284 
type of water consumed was not related to BC (Table 3). The median weekly duration 285 
for showering and washing dishes by hand was 40 min (IQR=30, 70) and 140 min 286 
(IQR=35, 210), respectively, and they were not correlated (Spearman correlation = 287 
0.004). Hand dish-washing was associated with BC with an OR of 1.39 (95%CI=1.05, 288 
1.83) for the highest vs. lowest quartile (p-trend of 0.013), also after adjusting by 289 
residential TTHMs. When combining residential THM levels with water activities, the 290 
estimated ingested THM levels were not associated with BC (Table 4). Some 291 
intermediate category of exposure to TTHMs and Br-THMs through showering was 292 
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protective for BC, while exposure through dish washing was positively related to BC 293 
(OR=1.93; 95%CI=1.47, 1.12 for the highest vs. lowest quartiles of TTHMs). Further 294 
adjustment by residential level of chloroform or Br-THMs did not affect the 295 
associations (results not shown).  296 
4. DISCUSSION 297 
For the first time, we estimated the association between life-time exposure to THMs in 298 
drinking water and female BC in a large case-control study, including areas with 299 
contrasting THM concentrations in Spain and evaluating different routes of exposure 300 
and THM species. At common levels in Europe, total THM exposure was not related to 301 
BC, but a positive association was suggested for exposure to chloroform.     302 
This case-control study includes several areas in Spain with a large variability in Br-303 
THMs and TTHM levels in drinking water. The proportion and correlation between 304 
chloroform and Br-THMs also varied considerably between areas, allowing detecting 305 
different associations with BC by THM species. When comparing the highest vs. lowest 306 
quartiles of exposure, residential chloroform in drinking water was associated with BC 307 
at >24 µg/L, while no association was detected for Br-THMs at >31 µg/L or for TTHM 308 
at >48 µg/L. However, the GAM models indicated a positive linear association with BC 309 
not only for chloroform but also for TTHM and Br-THMs, but a reduced number of 310 
subjects were exposed at the highest levels. A 7% of study participants had a median 311 
lifetime residential TTHM levels above the current maximum level in the EU of 100 312 
µg/L. These subjects were from the Barcelona metropolitan area, where Br-THMs have 313 
been especially high (median of 64.4 µg/L and IQR=48.8, 91.8) due to a high bromide 314 
content in the raw water. In this area, an increased OR was also detected for life-time 315 
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exposure to TTHMs and Br-THMs, although this was not statistically significant 316 
probably due to the reduced sample size.   317 
These results are difficult to compare since previous studies on DBP exposure and BC 318 
did not report DBP levels (Gottlieb et al. 1982; Kanarek et al. 1982; Koivusalo et al. 319 
1997; Vincetti et al. 2004; Young et al. 1981), but were based on surrogates of DBP 320 
exposure such as chlorinated vs. unchlorinated water (Kanarek et al. 1982, Koivusalo et 321 
al. 1997) or groundwater vs. surface water (Doyle et al. 1997). One exception is an 322 
ecological study in North Carolina published in 1998 (Marcus et al. 1998) that 323 
compared female BC rates by current levels of TTHMs and found a rate ratio of 1.1 324 
(95%CI=0.9, 1.2) for >80 µg/L vs. <40 µg/L (Marcus et al. 1998). A large study using 325 
data from the cancer registry in Finland also found a small increased risk of BC (RR= 326 
1.11 (95%CI=1.01, 1.22)) among women supplied by chlorinated surface water 327 
(Koivusalo et al. 1997). A part from a poor exposure assessment, previous 328 
epidemiological studies on BC and DBP exposure had other important methodological 329 
constrains, such as an ecological design (Marcus et al. 1998; Vincetti et al. 2004; 330 
Wilkins and Comstock 1981), the use of mortality instead of incidence data (Kanarek et 331 
al. 1982; Vincetti et al. 2004; Wilkins and Comstock 1981) or a poor assessment of 332 
relevant confounders. Therefore, the present study overcomes several limitations of 333 
previous studies and represents a step forward in the epidemiological evidence on DBP 334 
exposure and BC risk.  335 
Another novelty of the present study is the evaluation of individual patterns of water use 336 
such as type of ingested water or the frequency and duration of showering and hand 337 
dish-washing. Different health effects could be expected by these water activities since 338 
they reflect different exposure routes (ingestion, dermal absorption or inhalation) and 339 
different THM uptakes (Gordon et al. 2006). The significant association detected 340 
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between BC and exposure to chloroform was seen for residential levels but not for 341 
ingested chloroform. Similarly, residential TTHM levels has been the exposure 342 
indicator more related to bladder cancer (Costet et al. 2011; Villanueva et al. 2007) and 343 
ingested TTHM was also not related to this cancer in the largest international meta-344 
analysis (Costet et al. 2011). On one hand, residential THM levels are considered an 345 
indicator of global exposure regardless of the route (Costet et al. 2011) and on the other 346 
hand, the lack of association between cancer and ingested THM levels could be 347 
attributed to limitations in the measurement of the indicator more than to a real lack of 348 
effect of ingested DBPs (Costet et al. 2011). This is the first study on THM exposure 349 
and cancer risk to consider exposure through hand dish-washing and it was positively 350 
related to BC. Although THM uptake is lower when washing dishes by hand than when 351 
showering (Gordon et al. 2006), the duration of exposure and variability was much 352 
higher for hand dish-washing than showering (median of 140 and 40 min/week, 353 
respectively) in this study population limited to women. However, the fact that some 354 
protective association was seen between BC and showering and that hand dish-washing 355 
was related to BC risk beyond THM levels, suggests potential confounding by other 356 
unmeasured factors.  357 
The modelling of historical THM levels allowed us to estimate exposure for different 358 
temporal windows. However, very similar results were found between adult-lifetime 359 
exposure and exposure during the last 10 years, probably due to the high correlation 360 
between the levels at different exposure periods. Although the present study has done a 361 
huge improvement in exposure assessment compared to previous studies, some 362 
measurement error is probably still present due to the limited historical THM 363 
measurements. To minimize this, we exclude subjects having estimated THM levels for 364 
less than 70% of the exposure window. Inability to account for THM exposure outside 365 
17 
 
the home may have introduced error in the estimation of ingested THM levels, although 366 
most of total water was consumed at home (74%). Selection bias might be another 367 
concern, since response rates were low especially among controls that were population-368 
based and shared for different cancer sites within a larger multi-case control study, 369 
leading a slightly different age distribution than cases and higher educational level than 370 
general population. However, we assume that probability of participation is independent 371 
from the exposure, and we don’t expect an impact on the results due to response rates. 372 
Finally, we cannot rule out uncontrolled confounding by other water contaminants 373 
beyond DBPs. However, long-term exposure assessment to nitrate was conducted in this 374 
study (Espejo-Herrera et al. 2016) and adjusting models by nitrate exposure did not 375 
modified the results. Furthermore, unpublished data on selected pesticides in drinking 376 
water in the study area (e.g., simazine, atrazine, terbuthylazine) showed levels below or 377 
around the quantification limit. Residual confounding by socioeconomic status could be 378 
another concern, although different sensitivity analysis indicate no major effects of 379 
socioeconomic status on the estimated risks.  380 
Gastrointestinal and urinary tract, and not BC, are the cancer sites with higher biological 381 
plausibility to be affected by DBP exposure (Koivusalo 1997). However, biological 382 
mechanisms have been poorly investigated (Nieuwenhuijsen et al. 2009), being 383 
genotoxicity and carcinogenicity the most recognized ones (Richardson et al. 2007). 384 
Epigenetic changes in DNA methylation have also been suggested as another potential 385 
mechanism of DBP toxicity (Salas et al. 2015). DBPs are not considered important 386 
endocrine disruptors, but very little toxicological evidence is available (Klinefelter et al. 387 
2004). A toxicological study described a delay in reproductive development in rats due 388 
to long-term exposure to brominated haloacetic acids (Klinefelter 2004) and MX was 389 
found to be a potent carcinogen in rats that increased mammary gland tumours in female 390 
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rats (Komulainen et al. 1997). BC is a heterogeneous disease with potentially different 391 
aetiologies in pre- and postmenopausal women and in this study we found slightly 392 
higher associations between THM exposure and BC among pre-menopausal women at 393 
the highest exposure category.  394 
DBPs constitute a complex mixture with around 600 identified chemicals with different 395 
toxicity (Richardson et al., 2007). THMs are usually the more prevalent DBPs in 396 
drinking water but have lower toxicity than other less prevalent DBPs, such as 397 
haloacetonitriles or MX (Richardson et al. 2007). During the recruitment period of the 398 
present study, several DBPs were analysed in drinking water of a representative sample 399 
across study areas (Villanueva et al. 2012). Haloacetic acids (HAAs) were in a very 400 
similar range than TTHMs (median of 26.4 µg/L). Haloacetonitries, haloketones, 401 
chloropicrin and chloralhydrate were in much lower levels and below the limit of 402 
detection in several samples. MX showed a median (range) concentration of 16.7 (0.8–403 
54.1) ng/L. Chloroform concentration was positively correlated to chlorinated HAA and 404 
MX levels, while Br-THMs were positively correlated to brominated HAA (Villanueva 405 
et al. 2012).   406 
Epidemiological studies on DBP exposure and cancer risk have mainly used TTHMs as 407 
an indicator of exposure to the total mixture of DBPs (Villanueva et al. 2015). This may 408 
result in the misclassification of exposure to the relevant chemicals for a given health 409 
outcome, since the correlation between DBP constituents is complex and varies across 410 
areas and over time (Villanueva et al. 2012). Measuring the exposure to chloroform and 411 
Br-THMs allows estimating separately the exposure to overall chlorinated DBPs and 412 
brominated DBPs, since these species are usually correlated between them (Villanueva 413 
et al. 2012). This may be especially relevant in epidemiological studies including areas 414 
with different chlorine-bromine speciation, like the present one. In this study, female 415 
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BC appeared to be associated with lifetime exposure to common levels of chloroform 416 
but not Br-THMs or TTHMs. Chlorinated DBPs are usually found in higher 417 
concentrations in drinking water than brominated DBPs, but toxicological evidence 418 
indicates that the brominated are more genotoxic and cytotoxic than their chlorinated 419 
analogues (Richardson et al. 2007). Furthermore, current concentrations of MX in the 420 
study area were positively correlated to current chloroform level and negatively 421 
correlated to Br-THMs (Villanueva et al. 2012).  422 
5. CONCLUSIONS 423 
At common levels in Europe, long-term residential total THMs were not related to 424 
female breast cancer. A moderate association with chloroform was suggested at the 425 
highest exposure category. These results should be confirmed in future large and well 426 
design epidemiological studies, since they would have a large public health impact due 427 
to the ubiquity of DBP exposure and the health burden of BC.  428 
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Table 1. Description of the study population. N=2,461. 
 
Controls Cases  
 
N % N % p-value 
Total 1458 
 
1003   
Area 
  
   
Asturias 90 6.2 62 6.2  
Barcelona A 140 9.6 114 11.4  
Barcelona B 89 6.1 45 4.5  
Barcelona C 93 6.4 47 4.7  
Cantabria 149 10.2 86 8.6  
Guipuzcoa 239 16.4 119 11.9  
León 151 10.4 128 12.8  
Madrid 305 20.9 236 23.5  
Navarra 150 10.3 115 11.5  
Valencia 52 3.6 51 5.1  
Age, years 
  
   
Mean (SD) 59.4 (12.8) 57.1 (12.0)  
<=50 412 28.3 334 33.3  
51-60 346 23.7 278 27.7  
61-70 366 25.1 246 24.5  
>70 334 22.9 145 14.5  
Education 
  
   
< Primary school 243 16.7 144 14.4 0.417 
Primary school 465 31.9 331 33.0  
Secondary school 448 30.7 325 32.4  
University 302 20.7 203 20.2  
Menopausal status 
  
   
Post 1,063 72.9 671 66.9 0.005 
Pre 393 27.0 331 33.0  
DK/M 2 0.1 1 0.1  





No 1,149 78.8 651 64.9 <0.001 
Yes 252 17.3 321 32.0  
DK/M 57 3.9 31 3.1  
Body mass index, Kg/m2  
  
   
<25 745 51.1 477 47.6 0.189 
25-29.9 452 31.0 342 34.1  
30 or more 261 17.9 184 18.3  
Occupational status 
  
   
Working 556 38.1 483 48.2 <0.001 
Not working 87 6.0 71 7.1  
Housewife 480 32.9 247 24.6  
Retired 335 23.0 202 20.1  
Oral contraceptive use 
  
   
25 
 
Never 805 55.2 560 55.8 0.353 
Ever 652 44.7 440 43.9  
DK/M 1 0.1 3 0.3  
Menopause treatment 
  
   
Ever 294 20.2 150 15.0 <0.001 
Never 765 52.5 515 51.4  
Missing/Pre-menopause 399 27.4 338 33.7  
Physical activity a, METs 
  
   
0  891 61.1 676 67.4 0.002 
>0 to 8  272 18.7 162 16.2  
>10 to 16  121 8.3 84 8.4  
>16  174 11.9 81 8.1  
Energy intake, kcal/day 
  
   
<1500 452 31.0 251 25.0 0.007 
1500-2000 485 33.3 352 35.1  
>2000 351 24.1 284 28.3  
DK/M 170 11.7 116 11.6  
 
a. physical activity: metabolic equivalents (MET) total h/week; annual median in the last 10 
years.  




Figure 1. Average adult-lifetime residential levels of total trihalomethanes (TTHMs), 
chloroform and brominated trihalometanes (Br-THMs) among the study participants in 
the 10 study areas. N=2,461. 
 
Figure legend. The percentage in italics indicates de proportion of TTHMs that is 
chloroform. The vertical line inside each box indicates the median value. The lower and 










































Figure 2. Exposure-response curves between adult-lifetime residential THMs (µg/L) and breast 











































Figure legend. Tick marks above the x-axes represent quartiles of exposure. Models 
adjusted by area, age, educational level, occupational status, family history of BC, BMI, 
energy intake, physical activity, oral contraceptive use and menopause treatment use. P-
values for nonlinearity: 0.616 for TTHMs, 0.473 for chloroform, 0.300 for Br-THMs.  
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Table 2. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated 
with adult-lifetime residential levels of total trihalomethanes (TTHMs), chloroform and 
brominated trihalometanes (Br-THMs). N=2,461.  
 
Controls Cases ORa (95%CI) ORb 95%CI 
TTHMs (µg/L)       
<=21.7 365 209 1 
 
  
>21.7-30.5 364 245 1.15 (0.88, 1.49)   
>30.5-48.3 365 290 1.09 (0.81, 1.46)   
>48.3 364 259 1.14 (0.83, 1.57)   
Total 1,458 1,003 ptrend 0.503   
Cont. (10 µg/L) 
  
1.01 (0.97, 1.05)   
Chloroform (µg/L)       
<=7.6 365 198 1 
 
1  
>7.6-18.8 364 233 1.25 (0.95, 1.65) 1.22 (0.92, 1.62) 
>18.8-24.3 365 266 1.29 (0.96, 1.73) 1.25 (0.95, 1.65) 
>24.3 364 306 1.47 (1.05, 2.06) 1.40 (1.01, 1.95) 
Total 1,458 1,003 ptrend 0.028 ptrend 0.038 
Cont. (10 µg/L) 
  
1.12 (0.98, 1.27) 1.12 (0.98, 1.27) 
Br-THMs (µg/L)       
<=5.5 365 276 1 
 
1 1.00 
>5.5-10.1 364 282 1.08 (0.82, 1.41) 1.16 (0.84, 1.59) 
>10.1-31.0 365 197 0.79 (0.57, 1.10) 0.90 (0.64, 1.25) 
>31.0 364 248 0.91 (0.68, 1.23) 0.95 (0.67, 1.35) 
Total 1,458 1,003 ptrend 0.275 ptrend 0.378 
Cont. (10 µg/L) 
  
1.00 (0.96, 1.04) 0.99 (0.96, 1.03) 
     
  
 
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models 
with area as random effect. Exposure variables are categorized into quartiles. a. Models 
adjusted for age, educational level, occupational status, family history of BC, BMI, 
energy intake, physical activity, oral contraceptive use and menopause treatment use. b. 




Table 3. Frequency of water-related activities in the study population and related odds 








N % N % 
  Drinking water sourcea 
      
 
Tap/municipal 1,101 75.6 749 75.0 1 
 
 
Bottled 304 20.9 207 20.7 0.99 (0.79, 1.23) 
 
Wells/springs/other 51 3.5 42 4.2 1.07 (0.68, 1.68)  
 
Total 
   
2,454 
  Showering (min/week) 
      
 
<=30 374 26.5 260 26.5 1 
 
 
>30-40 356 25.2 265 27.0 0.95 (0.75, 1.22) 
 
>40-70 494 35.0 336 34.2 0.83 (0.66, 1.04)  
 
>70 188 13.3 121 12.3 0.82 (0.61, 1.10)  
     
2,394 ptrend 0.070 
Dish washing by hand 
(min/week) 
      
 
<=35 357 25.9 236 26.1 1 
 
 
35-140 439 31.9 271 29.9 0.95 (0.75, 1.20)  
 
>140-210 279 20.2 182 20.1 1.10 (0.84, 1.45) 
 
>210 303 22.0 216 23.9 1.39 (1.05, 1.83) 
     
2,283 ptrend 0.013 
 
Mixed models with area as random effect. Exposure variables are categorized into 
quartiles. Models adjusted for age, educational level, occupational status, family history 
of BC, BMI, energy intake, physical activity, oral contraceptive use and menopause 
treatment use. a. Drinking water source in the longest residency. 
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Table 4. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated with adult-lifetime exposure to total trihalomethanes 
(TTHMs), chloroform and brominated trihalomethanes (Br-THMs) through different exposure situations. N=2,461.  
TTHMs Contr. Cases OR 95%CI CHCl3 Contr. Cases OR 95%CI Br-THMs Contr. Cases OR 95%CI 
Ingestion (µg /day)              
<=15.0 366 254 1  <=5.5 365 248 1 
 
<=3.6 366 254 1 
 >15.0-23.8 363 204 0.91 (0.71, 1.18) >5.5-13.4 364 201 0.88 (0.68, 1.13) >3.6-6.7 363 273 1.04 (0.81, 1.32) 
>23.8-32.3 365 262 1.00 (0.77, 1.29) >13.4-23.1 365 275 1.16 (0.90, 1.50) >6.7-12.6 365 233 0.94 (0.72, 1.22) 
>32.3 364 282 1.05 (0.82, 1.35) >23.1 364 278 0.95 (0.71, 1.27)  >12.6 364 242 1.06 (0.81, 1.39) 
Total 1458 1002 ptrend 0.650 Total 1458 1002 ptrend 0.851 Total 1458 1002 ptrend 0.839 
Showering (µg/L*h/week)             
<=13.6 353 243 1  <=5.6 353 202 1 
 
<=3.9 353 299 1 
 13.6-23.1 353 270 0.99 (0.77, 1.26) 5.6-11.8 353 248 1.19 (0.92, 1.53) 3.9-7.6 353 236 0.72 (0.56, 0.92) 
>23.1-40.0 353 202 0.65 (0.50, 0.85) >11.8-21.0 353 285 1.16 (0.88, 1.52) >7.6-18.9 353 192 0.59 (0.45, 0.78) 
>40.0 353 267 0.91 (0.69, 1.20) >21.0 353 247 0.93 (0.70, 1.24) >18.9 353 255 0.76 (0.57, 1.01) 
Total 1412 982 ptrend 0.084 Total 1412 982 ptrend 0.497 Total 1412 982 ptrend 0.018 
Dishwashing (µg/L*h/week)             
<=13.6 345 222 1  <=4.8 345 211 1 
 
<=3.8 345 245 1 
 13.6-55.7 344 198 0.96 (0.74, 1.25) 4.8-26.5 344 196 1.05 (0.80, 1.36) 3.8-18.1 344 223 0.90 (0.70, 1.15) 
>55.7-119.9 345 210 1.01 (0.78, 1.30) >26.5-57.7 345 241 1.20 (0.93, 1.55) >18.1-58.3 345 173 0.80 (0.61, 1.05) 
>119.9 344 275 1.47 (1.12, 1.93) >57.7 344 257 1.34 (1.03, 1.73) >58.3 344 264 1.41 (1.04, 1.92) 
Total 1378 905 ptrend 0.009 Total 1378 905 ptrend 0.017 Total 1378 905 ptrend 0.154 
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models with recruitment area as random effect. Exposure variables 
are categorized into quartiles. Models adjusted by age, educational level, occupational status, family history of BC, BMI, energy intake, physical 
activity, oral contraceptive use and menopause treatment use. 
1 
 
SUPPLEMENTAL MATERIAL 1 
 2
Long-term exposure to trihalomethanes in drinking water and breast cancer 3 
in the Spanish multicase-control study on cancer (MCC-SPAIN) 4 
Laia Font-Ribera, Esther Gràcia-Lavedan, Nuria Aragonés, Beatriz Pérez-Gómez, 5 
Marina Pollán, Pilar Amiano, Ana Jiménez-Zabala, Gemma Castaño-Vinyals, Aina 6 
Roca-Barceló,  Eva Ardanaz, Rosana Burgui, Antonio José Molina, Tania Fernández-7 
Villa, Inés Gómez-Acebo, Trinidad Dierssen-Sotos, Victor Moreno, Guillermo 8 
Fernandez-Tardon, Rosana Peiró, Manolis Kogevinas, Cristina M Villanueva 9 
 10 
Table of contents 11 
• Figure S1. Geographical distribution of the residences of cases and controls of study 12 
subjects in the 10 study areas.  13 
• Figure S2. Scatter plot and Spearman correlations between adult-lifetime residential 14 
chloroform (X axes) and adult-lifetime residential Br-THMs (Y axes) in the 10 study 15 
areas and overall. 16 
• Table S1. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 17 
associated with classical BC risk factors.  18 
• Table S2. Differences between the included and the excluded population.  19 
• Table S3. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 20 
associated with adult-lifetime residential levels of total trihalomethanes (TTHMs), 21 
chloroform and brominated trihalometanes (Br-THMs), stratified by menopausal 22 
status. 23 
• Table S4. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 24 
associated with adult-lifetime residential levels of total trihalomethanes (TTHMs), 25 
chloroform and brominated trihalometanes (Br-THMs), stratified by educational 26 
level in two categories.  27 
• Table S5. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 28 
associated with adult-lifetime residential levels of total trihalomethanes (TTHMs), 29 
chloroform and brominated trihalometanes (Br-THMs), adjusted by further 30 
socioeconomic variables.  31 
• Table S6. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 32 
associated with residential levels of total trihalomethanes (TTHMs), chloroform and 33 
brominated trihalomethanes (Br-THMs) in the two largest metropolitan areas in 34 
Spain.  35 
• Table S7. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer 36 
associated with average residential levels of total trihalomethanes (TTHMs), 37 
2 
 
chloroform, and brominated trihalomethanes (Br-THMs) in the last 10 years. 1 
N=2,428.  2 
3 
 
Figure S1. Geographical distribution of the residences of cases and controls of study 1 























Figure S2. Scatter plot and Spearman correlations between adult-lifetime residential chloroform (X axes) and adult-lifetime residential Br-THMs (Y axes) in the 1 
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Table S1. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated 1 
with classical BC risk factors.  2 
 Controls Cases OR 95%CI 
Education 
 
   
< Primary school 243 144 1  
Primary school 465 331 1.03 (0.79, 1.34) 
Secondary school 448 325 0.93 (0.70, 1.23) 
University 302 203 0.81 (0.59, 1.11) 
Menopausal status 
 
   
Post 1,063 671 1  
Pre 393 331 1.00 (0.77, 1.29) 
DK/M 2 1 0.60 (0.05, 6.74) 





No 1,149 651 1  
Yes 252 321 2.22 (1.83, 2.70) 
DK/M 57 31 0.98 (0.62, 1.55) 
Body mass index, Kg/m2  
 
   
<25 745 477 1  
25-29.9 452 342 1.35 (1.12, 1.64) 
30 or more 261 184 1.27 (1.00, 1.60) 
Occupational status 
 
   
Working 556 483 1  
Not working 87 71 0.90 (0.64, 1.27) 
Housewife 480 247 0.69 (0.47, 0.77) 
Retired 335 202 0.74 (0.55, 0.98) 
Oral contraceptive use 
 
   
Never 805 560 1  
Ever 652 440 0.82 (0.69, 0.98) 
DK/M 1 3 4.33 (0.44, 42.86) 
Menopause treatment 
 
   
Ever 294 150 1  
Never 765 515 1.30 (1.04, 1.64) 
Missing/Pre-menopause 399 338 1.26 (0.93, 1.71) 
Physical activity a, METs 
 
   
0  891 676 1  
>0 to 8  272 162 0.75 (0.60, 0.93) 
>10 to 16  121 84 0.89 (0.66, 1.20) 
>16  174 81 0.60 (0.45, 0.79) 
Energy intake, kcal/day 
 
   
<1500 452 251 1  
1500-2000 485 352 1.29 (1.05, 1.59) 
>2000 351 284 1.39 (1.11, 1.74) 
DK/M 170 116 1.22 (0.91, 1.62) 
Age at first birth     
<25 378 243 1  
11 
 
25-28 422 277 1.07 (0.86, 1.34) 
>28 389 262 1.07 (0.84, 1.35) 
DK/M 269 221 1.26 (0.98, 1.63) 
Nulliparity      
No 1197 213 1  
Yes 260 213 1.20 (0.97, 1.48) 
Age at menarche (years)     
<=12 600 433 1  
13-14 668 453 0.96 (0.81, 1.15) 
>14 178 104 0.87 (0.66, 1.14) 
DK/M 12 13 1.77 (0.79, 3.95) 
Breastfeeding (months)     
0 464 349 1  
>0-6 418 317 1.00 (0.81, 1.22) 
>6-12 235 169 0.97 (0.76, 1.24) 
>12 341 168 0.70 (0.55, 0.89) 
Mixed models with recruitment area as random effect and adjusted by age and 1 
educational level. 2 
  3 
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N % N % p-value 
Total 
 
861 25.9 2,461 74.1 
 
       Case/control Controls 282 32.75 1,458 59.24 <0.001 
 
Cases 579 67.25 1,003 40.76 
 
       Area Asturias 21 2.44 152 6.18 <0.001 
 
Barcelona A 39 4.53 254 10.32 
 
 
Barcelona B 27 3.14 134 5.44 
 
 
Barcelona C 76 8.83 140 5.69 
 
 
Cantabria 94 10.92 235 9.55 
 
 
Guipuzcoa 123 14.29 358 14.55 
 
 
León 149 17.31 279 11.34 
 
 
Madrid 165 19.16 541 21.98 
 
 
Navarra 142 16.49 265 10.77 
 
 
Valencia 25 2.9 103 4.19 
 
       Age, years <=50 356 41.35 746 30.31 <0.001 
 
51-60 202 23.46 624 25.36 
 
 
61-70 130 15.1 612 24.87 
 
 
>70 173 20.09 479 19.46 
 
       Education <Primary school 150 17.42 387 15.73 0.33 
 
Primary school 253 29.38 796 32.34 
 
 
Secondary school 284 32.98 773 31.41 
 
 
University 174 20.21 505 20.52 
 
       Menopausal 
status postmenopausal 510 59.23 1,734 70.46 <0.001 
 
premenopausal 350 40.65 724 29.42 
 
 
DK/M 1 0.12 3 0.12 
 
       Family 
history of 
breast cancer No 606 70.38 1,800 73.14 0.283 
 
Yes 223 25.9 573 23.28 
 
 
missing 32 3.72 88 3.58 
 
       Body mass 
index, Kg/m2 <25.00 410 48.46 1,222 49.65 0.634 
 
25.00-29.99 288 34.04 794 32.26 
 
 
30.00 or more 148 17.49 445 18.08 
 
       Menopause 
treatment Ever 99 11.5 444 18.04 <0.001 
 





DK/M 352 40.88 737 29.95 
 
       Occupational 
status Working 426 49.48 1,039 42.22 <0.001 
 
Not working 66 7.67 158 6.42 
 
 
Housewife 202 23.46 727 29.54 
 
 
Retired 167 19.4 537 21.82 
 
       Oral 
contraceptive 
use Never 476 55.28 1,365 55.47 0.915 
 
Ever 383 44.48 1,092 44.37 
 
 
DK/M 2 0.23 4 0.16 
 
       Physical 
activitya, 
METs 0 562 66.51 1,567 63.67 0.102 
 
>0 to 8  118 13.96 434 17.64 
 
 
>10 to 16  76 8.99 205 8.33 
 
 
>16  89 10.53 255 10.36 
 
       Energy 
intake, 
kcal/day <1500 208 24.16 703 28.57 <0.001 
 
1500-2000 269 31.24 837 34.01 
 
 
>2000 225 26.13 635 25.8 
 
 
missing 159 18.47 286 11.62 
  1
a. physical activity: metabolic equivalents (METs) total h/week; annual median in the last 10 2 
years. DK/M: Don’t know or missing.  3 
p-values for  the chi2 test.  4 
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Table S3. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated with 
adult-lifetime residential levels of total trihalomethanes (TTHMs), chloroform and brominated 
trihalometanes (Br-THMs), stratified by menopausal status.  





 OR (95%CI) OR 95%CI OR 95%CI 
TTHMs (µg/L)       
<=21.7 1  1  1  
>21.7-30.5 1.15 (0.88, 1.49) 1.08 (0.66, 1.76) 1.15 (0.85, 1.58) 
>30.5-48.3 1.09 (0.81, 1.46) 1.21 (0.80, 1.81) 0.91 (0.62, 1.34) 
>48.3 1.14 (0.83, 1.57) 1.45 (0.90, 2.35) 1.12 (0.72, 1.74) 
Chloroform 
(µg/L)       
<=7.6 1  1  1  
>7.6-18.8 1.22 (0.92, 1.62) 1.33 (0.79, 2.22) 1.31 (0.93, 1.84) 
>18.8-24.3 1.25 (0.95, 1.65) 1.20 (0.77, 1.89) 1.38 (0.95, 2.01) 
>24.3 1.40 (1.01, 1.95) 1.50 (1.00, 2.26) 1.39 (0.89, 2.16) 
Br-THMs (µg/L)       
<=5.5 1  1  1  
>5.5-10.1 1.16 (0.84, 1.59) 1.18 (0.77, 1.79) 1.00 (0.69, 1.43) 
>10.1-31.0 0.90 (0.64, 1.25) 0.88 (0.57, 1.35) 0.70 (0.45, 1.08) 
>31.0 0.95 (0.67, 1.35) 1.26 (0.78, 2.03) 0.78 (0.51, 1.21) 
 
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models with area 
as random effect. Exposure variables are categorized into quartiles. Models adjusted for age, 
educational level, occupational status, family history of BC, BMI, energy intake, physical 
activity, oral contraceptive use and menopause treatment use. Chloroform and Br-THMs models 
mutually adjusted for chloroform and Br-THMs. p-values for interaction between THMs and 
menopausal status on BC > 0.05.  
 
 1
  2 
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Table S4. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated with 
adult-lifetime residential levels of total trihalomethanes (TTHMs), chloroform and brominated 
trihalometanes (Br-THMs), stratified by educational level in two categories.  
 
 ALL  N=2,461 Primary or less N=1183 
Secondary & university 
N=1278 
 OR (95%CI) OR 95%CI OR 95%CI 
TTHMs (µg/L)       
<=21.7 1  1  1  
>21.7-30.5 1.15 (0.88, 1.49) 1.21 (0.83, 1.75) 1.10 (0.74, 1.62) 
>30.5-48.3 1.09 (0.81, 1.46) 0.94 (0.59, 1.50) 1.15 (0.76, 1.73) 
>48.3 1.14 (0.83, 1.57) 1.12 (0.73, 1.72) 1.17 (0.71, 1.93) 
Chloroform 
(µg/L)       
<=7.6 1  1  1  
>7.6-18.8 1.22 (0.92, 1.62) 1.23 (0.86, 1.76) 1.21 (0.82, 1.80) 
>18.8-24.3 1.25 (0.95, 1.65) 1.41 (0.98, 2.01) 1.05 (0.69, 1.58) 
>24.3 1.40 (1.01, 1.95) 1.16 (0.75, 1.77) 1.62 (1.03, 2.54) 
Br-THMs (µg/L)       
<=5.5 1  1  1  
>5.5-10.1 1.16 (0.84, 1.59) 0.67 (0.45, 1.00) 1.93 (1.22, 3.05) 
>10.1-31.0 0.90 (0.64, 1.25) 0.74 (0.49, 1.11) 1.19 (0.72, 1.99) 
>31.0 0.95 (0.67, 1.35) 0.69 (0.48, 1.01) 1.36 (0.83, 2.24) 
 
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models with area 
as random effect. Exposure variables are categorized into quartiles. Models adjusted for age, 
educational level, occupational status, family history of BC, BMI, energy intake, physical 
activity, oral contraceptive use and menopause treatment use. Chloroform and Br-THMs models 
mutually adjusted for chloroform and Br-THMs.  
 1 
  2 
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Table S5. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated with 
adult-lifetime residential levels of total trihalomethanes (TTHMs), chloroform and brominated 
trihalometanes (Br-THMs), adjusted by further socioeconomic variables.  
 
 Main models  N=2,461 
Models further 
adjusted by social 




adjusted by parental 
socioeconomic status  
N=2,398 
Models further 
adjusted by partner 
educational level 
N=2,446 
 OR (95%CI) OR 95%CI OR 95%CI OR 95%CI 
TTHMs 
(µg/L)         
<=21.7 1  1  1  1  
>21.7-30.5 1.15 (0.88, 1.49) 1.10 (0.83, 1.47) 1.19 (0.91, 1.54) 1.16 (0.89, 1.51) 
>30.5-48.3 1.09 (0.81, 1.46) 1.10 (0.81, 1.50) 1.15 (0.86, 1.53) 1.09 (0.81, 1.46) 
>48.3 1.14 (0.83, 1.57) 1.35 (0.97, 1.86) 1.38 (1.03, 1.84) 1.17 (0.84, 1.62) 
Chloroform 
(µg/L)         
<=7.6 1  1  1  1  
>7.6-18.8 1.22 (0.92, 1.62) 1.29 (0.98, 1.70) 1.37 (1.06, 1.77) 1.23 (0.92, 1.64) 
>18.8-24.3 1.25 (0.95, 1.65) 1.17 (0.89, 1.53) 1.24 (0.96, 1.60) 1.25 (0.93, 1.68) 
>24.3 1.40 (1.01, 1.95) 1.26 (0.92, 1.72) 1.38 (1.03, 1.85) 1.43 (1.01, 2.02) 
Br-THMs 
(µg/L)         
<=5.5 1  1  1  1  
>5.5-10.1 1.16 (0.84, 1.59) 1.26 (0.94, 1.70) 1.17 (0.89, 1.54) 1.16 (0.84, 1.59) 
>10.1-31.0 0.90 (0.64, 1.25) 0.87 (0.63, 1.21) 0.87 (0.65, 1.18) 0.91 (0.64, 1.28) 
>31.0 0.95 (0.67, 1.35) 1.19 (0.90, 1.58) 1.16 (0.89, 1.51) 0.96 (0.67, 1.38) 
 
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models with area 
as random effect. Exposure variables are categorized into quartiles. Models adjusted for age, 
educational level, occupational status, family history of BC, BMI, energy intake, physical 
activity, oral contraceptive use and menopause treatment use. Chloroform and Br-THMs models 
mutually adjusted for chloroform and Br-THMs.  
 1 
  2 
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Table S6. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated 1 
with residential levels of total trihalomethanes (TTHMs), chloroform and brominated 2 
trihalomethanes (Br-THMs) in the two largest metropolitan areas in Spain.  3 
   

















) <=71.1 82 36 1 
 
  
>71.1-87.3 80 74 1.77 (0.96, 3.26)   
>87.3-110.5 80 37 0.80 (0.39, 1.65)   
>110.5 80 59 1.72 (0.79, 3.78)   
Total 322 206 ptrend 0.441   











) <=17.8 81 42 1 
 
1  
>17.8-20.6 81 45 1.13 (0.62, 2.07) 1.08 (0.56, 2.06) 
>20.6-23.9 80 44 1.16 (0.54, 2.50) 1.31 (0.54, 3.19) 
>23.9 80 75 1.57 (0.72, 3.40) 1.62 (0.67, 3.91) 
Total 322 206 ptrend 0.219  0.223 










) <=48.8 82 40 1 
 
1  
>48.8-64.4 80 70 1.56 (0.87, 2.78) 1.46 (0.80, 2.67) 
>64.4-91.8 80 39 0.77 (0.38, 1.54) 0.76 (0.37, 1.57) 
>91.8 80 57 1.76 (0.80, 3.90) 1.87 (0.78, 4.50) 
Total 322 206 ptrend 0.478  0.478 

















) <=29.4 78 67 1 
 
  
>29.4-32.4 76 49 0.67 (0.40, 1.12)   
>32.4-34.4 75 57 0.89 (0.54, 1.48)   
>34.4 76 63 1.15 (0.70, 1.91)   
Total 305 236 ptrend 0.595   











) >=25.6 77 69 1 
 
1  
>25.6-28.5 76 45 0.65 (0.39, 1.09) 0.64 (0.33, 1.25) 
>28.5-30.3 78 62 0.92 (0.56, 1.53) 0.79 (0.36, 1.75) 
>30.3 74 60 1.19 (0.71, 1.98) 1.16 (0.51, 2.59) 
Total 305 236 ptrend 0.674  0.572 










) <3.5 77 64 1 
 
1  
>3.5-3.8 76 50 0.72 (0.43, 1.21) 0.91 (0.44, 1.88) 
>3.8-4.0 76 69 1.04 (0.62, 1.73) 1.24 (0.53, 2.92) 
>4.0 76 53 0.78 (0.46, 1.32) 0.74 (0.33, 1.67) 
Total 305 236 ptrend 0.962  0.703 
     
  
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Models in the 4 
Barcelona metropolitan area are mixed models with recruitment area as random effect. 5 
Models in Madrid are logistic regressions. Exposure variables are categorized into 6 
quartiles. a. Models adjusted by age, educational level, occupational status, family 7 
history of BC, BMI, energy intake, physical activity, oral contraceptive use and 8 
menopause treatment use. b. Models mutually adjusted for chloroform and Br-THMs.  9 
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Table S7. Odds ratio (OR) and 95% confidence interval (CI) of breast cancer associated 1 
with average residential levels of total trihalomethanes (TTHMs), chloroform, and 2 
brominated trihalomethanes (Br-THMs) in the last 10 years. N=2,428.  3 
 4
 
Controls Cases ORa 95%CI ORb 95%CI 
TTHM (µg/L)       
<=21.2 391 225 1 
 
  
21.2-30.3 361 242 1.03 (0.71, 1.51)   
>30.3-40.7 329 262 1.21 (0.84, 1.72)   
>40.7 360 258 1.16 (0.84, 1.60)   
Total 1441 987 ptrend 0.215   
Cont. (10 µg/L) 
  
0.99 (0.95, 1.03)   
     
  
Chloroform 
(µg/L)       
<=7.6 386 203 1 
 
1  
7.6-21.7 352 271 1.61 (1.13, 2.29) 1.79 (1.20, 2.67) 
>21.7-24.8 358 220 1.11 (0.77, 1.60) 1.31 (0.84, 2.03) 
>24.8 345 293 1.53 (1.08, 2.18) 1.84 (1.20, 2.82) 
Total 1441 987 ptrend 0.038 ptrend 0.022 
Cont. (10 µg/L) 
  
1.12 (1.00, 1.26) 1.11 (0.99, 1.25) 
     
  
BrTHM (µg/L)       
<=7.0 368 296 1 
 
1  
7.0-8.1 377 205 0.71 (0.49, 1.03) 0.73 (0.48, 1.11) 
>8.1-37.9 338 237 1.05 (0.71, 1.54) 1.25 (0.80, 1.96) 
>37.9 358 249 0.90 (0.59, 1.36) 0.90 (0.51, 1.57) 
Total 1441 987 ptrend 0.815 ptrend 0.371 
Cont. (10 µg/L) 
  
0.98 (0.95, 1.03) 0.99 (0.96, 1.03) 
     
  
TTHMs: total trihalomethanes. Br-THMs: brominated trihalometanes. Mixed models 5 
with recruitment area as random effect. a. Models adjusted by age, educational level, 6 
occupational status, family history of BC, BMI, energy intake, physical activity, oral 7 
contraceptive use and menopause treatment use. b. Models mutually adjusted for 8 
chloroform and Br-THMs. 9 
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